Page 5 - IDEA Studie 10 2022 Ztraty prijmu v pandemii
P. 5

                                                            Study 10/2022 Income Loss Compensation during the Covid-19 Pandemic: The Winners and the Losers2 JULY 2022 KLÁRA KALÍŠKOVÁ, LUCIE ZAPLETALOVÁ Summary of key findings ● In this study we analyze how income compensation tools adopted by the Czech government in response to the Covid-19 pandemic were targeted at various groups of households. We reveal what proportion of the state’s overall expenditure on compensatory measures was targeted to the households most heavily affected by the pandemic. ● Despite the fact that the state spent a substantial amount on measures to compensate households for loss of income, the pandemic still had a substantially heavier impact onthepoorerlayersofsociety.Thismaymanifestitselfinthefutureasadeepeningof existing problems with debt, executions and child poverty. ● Our analysis is based on unique data from a continuous survey of a sample of households that was collected as part of PAQ Research’s ‘Life During the Pandemic’ project in collaboration with IDEA at CERGE-EI and with financial support from the Czech Academy of Sciences. The data on household income structure are from the SILC survey run by the Czech Statistical Office and our simulations are performed using our own TAXBEN model. 2 This study represents the authors’ own views and not the official position of the Economics Institute of the Czech Academy of Sciences nor the Charles University Center for Economic Research and Graduate Education (CERGE). The authors would like to thank Daniel Münich, Michal Šoltés and Daniel Prokop for their valuable comments and suggestions for improving the study, and to a number of colleagues for helpful comments on working versions of the calculations and text. Any remaining errors are the authors’ own. This study was created within the project “Mapping the effects of the economic crisis and optimizing the systems of taxes, benefits, executions and insolvencies to mitigate its adverse effects” (No. TL04000332), which was co-financed by the Technology Agency of the Czech Republic. The study was also supported by the Czech Academy of Sciences as a part of Strategy AV21.    3 


































































































   3   4   5   6   7